We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bullfrog AI Holdings Inc (BFRG) USD0.00001

Sell:$2.62 Buy:$2.82 Change: $0.34 (11.26%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$2.62
Buy:$2.82
Change: $0.34 (11.26%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$2.62
Buy:$2.82
Change: $0.34 (11.26%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Contact details

Address:
323 Ellington Blvd, Unit 317
GAITHERSBURG
20878
United States
Telephone:
+1 (240) 6586710
Website:
https://www.bullfrogai.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BFRG
ISIN:
US12021E1091
Market cap:
$21.20 million
Shares in issue:
7.85 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Vininder Singh
    Chief Executive Officer, Director
  • Dane Saglio
    Chief Financial Officer
  • Enrique Garca-Rivera
    Vice President - Artificial Intelligence
  • Toby Sayre
    Vice President - Business Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.